Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
Use this OVID page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the OVID quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the OVID SEC filings page. Lician reads the product cache first so this HTML stays unique to Ovid Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full OVID income, balance, and cash tables.